Market Overview:
The global metagenomics market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for metagenomics-based diagnostics and therapeutics, rising awareness about the benefits of metagenomics, and technological advancements in sequencing and bioinformatics tools. The sequencing segment is expected to account for the largest share of the global metagenomics market in 2018. This segment is projected to grow at a CAGR of 17% during the forecast period. The bioinformatics segment is projected to grow at a CAGR of 15% during the same period. The infectious disease diagnosis application segment is expected to account for the largest share of the global metagenomics market in 2018.
Product Definition:
Metagenomics is the study of genetic material recovered directly from environmental samples. The importance of metagenomics comes from its ability to provide a comprehensive view of the genes and proteins present in an environment, including those that cannot be cultured in the laboratory.
Sequencing:
Sequencing is a process of determining the order of nucleotides in a particular sequence. It is used for genetic research, protein sequencing, and de novo assembly. Sequencing can be done with the help of PCR or by using an enzyme that cuts the DNA into pieces and allows determination of order based on how long each piece takes to assemble back together. The longer it takes to assemble back together, the higher is its score.
Bioinformatics:
Bioinformatics is the study of biological data. It includes methods for processing and analysis of DNA, RNA, proteins as well as metabolites. Bioinformatics also deals with information storage and retrieval in living organisms. The bio-component in metagenomics refers to the use of computational biology tools for analyzing microbial communities found in biomes such as soil, water or rock samples by identifying genes that are shared between taxonomic groups (e.g., bacterial genera).
Application Insights:
The infectious disease diagnosis segment dominated the global metagenomics market in terms of revenue in 2017. This is due to the rising prevalence of infectious diseases, such as HIV, tuberculosis and influenza. The environmental remediation application segment is expected to witness lucrative growth over the forecast period owing to increasing awareness about environmental contamination and its effects on human health.
Metagenomics has been proved helpful in food safety applications by detecting harmful bacteria or viruses that are present at low frequencies but can cause severe infections when they do occur. It has also been used for identifying new drugs that can cure different types of infections by discovering new antimicrobial compounds existing in nature or produced through chemical synthesis. Other applications include studies related to human health (epidemiology), animal health (disease diagnosis) and plant health (plant breeding).
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. This can be attributed to the presence of a substantial number of sequencing centers and metagenomics projects, such as Human Microbiome Project Consortium, which is an international research project on human-microbe interactions funded by National Institutes of Health (NIH). The U.S.-based company de novo Genomics has developed a platform for direct analysis of bacterial communities from environmental samples using high-throughput techniques. Such initiatives are expected to boost regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing government funding for genome studies coupled with rising awareness among people about their health and genetic information leading them towards proactive participation in clinical trials and other research activities resulting into higher revenue generation capacity within this region during the forecast period. Moreover, growing interest among individuals regarding personalized medicine solutions will further propel regional growth during the projected time frame (2018 - 2030).
Growth Factors:
- Increasing demand for personalized medicine
- Growing awareness about the benefits of metagenomics
- Technological advancements in sequencing and bioinformatics tools
- Rising investment in research and development of metagenomics products and services
- Growing number of collaborations between academia, government agencies, and private companies
Scope Of The Report
Report Attributes
Report Details
Report Title
Metagenomics Market Research Report
By Type
Sequencing, Bioinformatics
By Application
Infectious Disease Diagnosis, Environmental Remediation, Others
By Companies
F. Hoffmann-La Roche, PerkinElmer, Thermo Fisher Scientific, The MITRE Corporation, Quest Diagnostics, Agilent Technologies, Aperiomics, Promega, Oxford Nanopore, Enterome SA, Swift Biosciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Metagenomics Market Report Segments:
The global Metagenomics market is segmented on the basis of:
Types
Sequencing, Bioinformatics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infectious Disease Diagnosis, Environmental Remediation, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F. Hoffmann-La Roche
- PerkinElmer
- Thermo Fisher Scientific
- The MITRE Corporation
- Quest Diagnostics
- Agilent Technologies
- Aperiomics
- Promega
- Oxford Nanopore
- Enterome SA
- Swift Biosciences
Highlights of The Metagenomics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sequencing
- Bioinformatics
- By Application:
- Infectious Disease Diagnosis
- Environmental Remediation
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Metagenomics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Metagenomics is the study of all genetic material found in a sample, including DNA, RNA, and proteins.
Some of the major companies in the metagenomics market are F. Hoffmann-La Roche, PerkinElmer, Thermo Fisher Scientific, The MITRE Corporation, Quest Diagnostics, Agilent Technologies, Aperiomics, Promega, Oxford Nanopore, Enterome SA, Swift Biosciences.
The metagenomics market is expected to register a CAGR of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Metagenomics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Metagenomics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Metagenomics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Metagenomics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Metagenomics Market Size & Forecast, 2018-2028
4.5.1 Metagenomics Market Size and Y-o-Y Growth
4.5.2 Metagenomics Market Absolute $ Opportunity
Chapter 5 Global Metagenomics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Metagenomics Market Size Forecast by Type
5.2.1 Sequencing
5.2.2 Bioinformatics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Metagenomics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Metagenomics Market Size Forecast by Applications
6.2.1 Infectious Disease Diagnosis
6.2.2 Environmental Remediation
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Metagenomics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Metagenomics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Metagenomics Analysis and Forecast
9.1 Introduction
9.2 North America Metagenomics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Metagenomics Market Size Forecast by Type
9.6.1 Sequencing
9.6.2 Bioinformatics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Metagenomics Market Size Forecast by Applications
9.10.1 Infectious Disease Diagnosis
9.10.2 Environmental Remediation
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Metagenomics Analysis and Forecast
10.1 Introduction
10.2 Europe Metagenomics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Metagenomics Market Size Forecast by Type
10.6.1 Sequencing
10.6.2 Bioinformatics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Metagenomics Market Size Forecast by Applications
10.10.1 Infectious Disease Diagnosis
10.10.2 Environmental Remediation
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Metagenomics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Metagenomics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Metagenomics Market Size Forecast by Type
11.6.1 Sequencing
11.6.2 Bioinformatics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Metagenomics Market Size Forecast by Applications
11.10.1 Infectious Disease Diagnosis
11.10.2 Environmental Remediation
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Metagenomics Analysis and Forecast
12.1 Introduction
12.2 Latin America Metagenomics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Metagenomics Market Size Forecast by Type
12.6.1 Sequencing
12.6.2 Bioinformatics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Metagenomics Market Size Forecast by Applications
12.10.1 Infectious Disease Diagnosis
12.10.2 Environmental Remediation
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Metagenomics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Metagenomics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Metagenomics Market Size Forecast by Type
13.6.1 Sequencing
13.6.2 Bioinformatics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Metagenomics Market Size Forecast by Applications
13.10.1 Infectious Disease Diagnosis
13.10.2 Environmental Remediation
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Metagenomics Market: Competitive Dashboard
14.2 Global Metagenomics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 F. Hoffmann-La Roche
14.3.2 PerkinElmer
14.3.3 Thermo Fisher Scientific
14.3.4 The MITRE Corporation
14.3.5 Quest Diagnostics
14.3.6 Agilent Technologies
14.3.7 Aperiomics
14.3.8 Promega
14.3.9 Oxford Nanopore
14.3.10 Enterome SA
14.3.11 Swift Biosciences
